Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Novavax, Inc. (NVAX)

Fortrea Holdings Inc. and Novavax, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Novavax, Inc. are of similar size ($2.2B and $2.1B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −2.09% against −61.6%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −59.9%) and the lower return on invested capital (−0.48% vs 0.00%). Across the 17 metrics below, Fortrea Holdings Inc. leads on 9 and Novavax, Inc. on 8.

Valuation

Metric FTRE NVAX Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 4.48 9.71
P/B 4.07 n/m 2.13
Price to free cash flow 10.77 n/m 20.82
EV/EBITDA 44.71 n/m 0.64
EV/Sales 1.13 3.45 9.21
Earnings yield (4.05%) (13.50%) (33.15%)
Free cash flow yield 9.29% (2.38%) (25.50%)

Profitability

Metric FTRE NVAX Biotechnology median
Gross margin 19.30% 78.60% 65.16%
Operating margin (0.40%) (56.58%) 0.00%
Net margin (3.18%) (59.87%) 0.00%
Free cash flow margin 7.40% (10.20%) 0.00%
Return on equity (15.30%) 323.66% (56.36%)
Return on assets (3.07%) (21.62%) (48.04%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE NVAX Biotechnology median
Revenue growth (TTM) (2.09%) (61.64%) 6.02%
EPS growth (last fiscal year) (194.55%) 309.76% 30.26%
Revenue growth, 5-year CAGR 1.09% 18.76% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE NVAX Biotechnology median
Debt to equity 2.01 (1.54) 0.00
Current ratio 0.96 2.33 4.72
Net debt to EBITDA 266.13 (1.04) 0.96

Dividend

Metric FTRE NVAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTRE NVAX Biotechnology median
Market cap 2.16b 2.11b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack